Market Overview:
The global lincomycin market is expected to grow at a CAGR of 3.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for animal drugs and feed additives. North America is expected to dominate the global lincomycin market during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
Lincomycin is a lincosamide antibiotic that inhibits bacterial protein synthesis. It is used to treat a variety of infections, including pneumonia, strep throat, and bone infections.
High Purity Type:
High Purity Type is also known as HPT, it's a type of antibiotic used in the treatment of bacterial infections. It works by killing the bacteria that causes infection. The drug has low toxicity and is highly effective for urinary tract infections (UTIs), pneumonia, bloodstream infection (BSI) and ventilator-associated pneumonia (VAP).
The global high purity type market was valued at USD 648 million in 2016.
Normal Type:
Normal type is a term used for classification of Lincomycin tablets and capsules. It helps in determining the average size, shape and color of particles that are to be administered. The normal type can also help in identifying the exact strength as well as identify any possible variation in particle size which may or may not be related to efficacy.
Lincomycin hydrochloride powder was developed by GlaxoSmithKline Pharmaceuticals Ltd.
Application Insights:
Lincomycin is used in the treatment of animals as well as humans. In terms of usage in animals, it is majorly used for the treatment of respiratory diseases such as asthma and bronchitis. It can be given to pigs, dogs and horses with bacterial infections including pneumonia. The drug has a high potential for use in human medicine owing to its ability to treat various bacterial infections caused by different types of bacteria such as Staphylococcus aureus, Escherichia coli etc. However, its application is limited only to certain types due to resistance development after extensive useage which needs further research studies over lincomycin-based drugs for human consumption especially during antibiotic apocalypse period (third world war).
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to rising product demand from feed additives and animal drug applications. China is estimated to be one of the fastest-growing markets for lincomycin globally, on account of increasing R&D investments by domestic companies coupled with government support for innovation and development of pharmaceutical products.
In addition, favorable regulatory policies are projected to drive regional growth over the coming years as it will help promote new investment opportunities in this industry space.
Growth Factors:
- Increasing prevalence of infectious diseases: The increasing prevalence of infectious diseases is one of the key growth drivers for the lincomycin market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. These infections can cause a wide range of symptoms, depending on the site and severity of infection. The increasing incidence of infectious diseases is attributed to various factors such as changing lifestyles, growing population, and global warming. This is expected to drive the demand for lincomycin in the coming years.
- Rising demand for antibiotics: Antibiotics are drugs that are used to treat infections caused by bacteria or other microorganisms. They work by killing or stopping the growth of these organisms. The rising demand for antibiotics due to their efficacy in treating various types of infections is expected to boost the growth prospects for lincomycin market in future years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Lincomycin Market Research Report
By Type
High Purity Type, Normal Type
By Application
Animal Drugs, Animal Feed Additives
By Companies
Huvepharma, Tairui, Xinyu Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Lincomycin Market Report Segments:
The global Lincomycin market is segmented on the basis of:
Types
High Purity Type, Normal Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Animal Drugs, Animal Feed Additives
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Huvepharma
- Tairui
- Xinyu Pharma
Highlights of The Lincomycin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- High Purity Type
- Normal Type
- By Application:
- Animal Drugs
- Animal Feed Additives
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lincomycin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lincomycin is a antibiotic that is used to treat a variety of infections, including pneumonia, bronchitis, and urinary tract infections. It is also used to treat serious skin and soft tissue infections. Lincomycin can be taken by mouth or injected into the body.
Some of the major players in the lincomycin market are Huvepharma, Tairui, Xinyu Pharma.
The lincomycin market is expected to register a CAGR of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lincomycin Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Lincomycin Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Lincomycin Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Lincomycin Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Lincomycin Market Size & Forecast, 2018-2028 4.5.1 Lincomycin Market Size and Y-o-Y Growth 4.5.2 Lincomycin Market Absolute $ Opportunity
Chapter 5 Global Lincomycin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Lincomycin Market Size Forecast by Type
5.2.1 High Purity Type
5.2.2 Normal Type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Lincomycin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Lincomycin Market Size Forecast by Applications
6.2.1 Animal Drugs
6.2.2 Animal Feed Additives
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lincomycin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lincomycin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Lincomycin Analysis and Forecast
9.1 Introduction
9.2 North America Lincomycin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Lincomycin Market Size Forecast by Type
9.6.1 High Purity Type
9.6.2 Normal Type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Lincomycin Market Size Forecast by Applications
9.10.1 Animal Drugs
9.10.2 Animal Feed Additives
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Lincomycin Analysis and Forecast
10.1 Introduction
10.2 Europe Lincomycin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Lincomycin Market Size Forecast by Type
10.6.1 High Purity Type
10.6.2 Normal Type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Lincomycin Market Size Forecast by Applications
10.10.1 Animal Drugs
10.10.2 Animal Feed Additives
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Lincomycin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Lincomycin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Lincomycin Market Size Forecast by Type
11.6.1 High Purity Type
11.6.2 Normal Type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Lincomycin Market Size Forecast by Applications
11.10.1 Animal Drugs
11.10.2 Animal Feed Additives
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Lincomycin Analysis and Forecast
12.1 Introduction
12.2 Latin America Lincomycin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Lincomycin Market Size Forecast by Type
12.6.1 High Purity Type
12.6.2 Normal Type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Lincomycin Market Size Forecast by Applications
12.10.1 Animal Drugs
12.10.2 Animal Feed Additives
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Lincomycin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Lincomycin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Lincomycin Market Size Forecast by Type
13.6.1 High Purity Type
13.6.2 Normal Type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Lincomycin Market Size Forecast by Applications
13.10.1 Animal Drugs
13.10.2 Animal Feed Additives
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lincomycin Market: Competitive Dashboard
14.2 Global Lincomycin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Huvepharma
14.3.2 Tairui
14.3.3 Xinyu Pharma